Fantastic news! I can share with you as of 2pm today the Scottish Medicines Consortium (SMC) have announced that they have accepted the medicine: Caplacizumab through an expedited approach to minimise delay in patient access following the early phase of the COVID-19 pandemic.
This means that Caplacizumab will be licensed for use in Scotland.
Thank you to everyone who provided evidence about their experience of Capla and their experience of TTP in general. Your comments have made the difference to this decision.
